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Abstract 
Liver abscesses are both a significant economic loss and animal health and welfare 
concern for the beef cattle feedlot industry. Currently, in-feed antibiotics are used daily 
throughout the finishing period to decrease prevalence and severity of liver abscesses seen at the 
time of slaughter. The use of antibiotics in food animal production has been under scrutiny by 
consumers and the associated emergence and dissemination of antibiotic resistance is of public 
health concern. The most common antibiotic used to prevent liver abscesses is tylosin, a 
macrolide antibiotic. This antibiotic class has been deemed a critically important drug class to 
human medicine by the FDA, and therefore tylosin is regulated by the Veterinary Feed Directive. 
The goal of this research was to assess the effect of liver abscesses on meat tenderness and 
sensory traits and evaluate the safety and efficacy of an autogenous vaccine, an antibiotic 
alternative, against Fusobacterium necrophorum at reducing liver abscess prevalence and 
severity in feedlot cattle. The first study assessed the Warner Bratzler Shear Force, Slice Shear 
Force, and meat sensory panel results for strip loin steaks in a 3 × 2 factorial treatment structure 
including variables of quality grade: Choice and Select in relation to liver abscess treatment 
group: normal, mild, and severely abscessed livers. The results of this study showed that liver 
abscess status had no effect on Warner-Braztler Shear Force or Slice Shear Force but in sensory 
analysis, quality grade select steaks from cattle with mild liver abscesses were found to have 
greater myofibril tenderness than those with severe liver abscesses. The second study assessed 
the safety of an experimental autogenous liver abscess vaccine with three different proprietary 
adjuvant combinations, adjuvant 1 at 20% concentration, adjuvant 1 at 10% concentration, and 
adjuvant 2 at 15% concentration in beef cattle. All three antigen-adjuvant combinations were 
safe and did not elevate body temperature. The final study assessed the efficacy of an autogenous 
  
vaccine in a commercial feedlot on cattle enrolled in a “natural” cattle program, therefore raised 
without antibiotics. This study found that the vaccine did not reduce prevalence or severity of 
liver abscesses in feedlot cattle that had been fed an average of 206 days. The research outlined 
in this dissertation adds to the existing body of work about the effects of liver abscesses on 
carcass quality and outlines the safety and efficacy of an autogenous vaccine developed with the 
goal of reducing liver abscess prevalence. Liver abscesses in fed cattle must be addressed to 
improve animal health and welfare and increase profit for producers in an already small margins 
industry. 
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Chapter 1 - Non-antimicrobial alternatives for liver abscess 
prevention in feedlot cattle: A review  
 Introduction 
Liver abscesses are a common animal welfare issue in feeder cattle and an economic loss 
for producers in the United States cattle feeding industry. Currently, liver abscesses are 
controlled with the use of in-feed antibiotics however the use of antibiotics in livestock is 
becoming increasingly regulated. Consumer perception surrounding antimicrobial use, 
particularly used as preventative measures in healthy animals, is a growing concern. It is 
essential to find a method to prevent liver abscesses in cattle that doesn’t require the use of 
antibiotics and keeps beef production economically sustainable. This review will discuss various 
topics surrounding liver abscessation in feedlot cattle including:  bacteriology, pathophysiology, 
economic impact, the current use of antibiotics to prevent abscesses, possible non-antibiotic 
prevention tools and roughage inclusion levels in feedlot diets.  
 Bacteriology 
The most common bacterial pathogen isolated in liver abscesses in cattle is 
Fusobacterium necrophorum, sp. necrophorum (F. necrophorum).  Fusobacterium necrophorum 
has been isolated from up to 100% of liver abscesses seen at the time of slaughter (Nagaraja and 
Chengapa, 1998; Nagaraja et al., 1999a). Truperella pyogenes (T. pyogenes) is the second most 
common pathogen identified, often found in combination with F. necrophorum (Nagaraja et al., 
1999a). Other bacteria that have been isolated from liver abscesses include Bacteriodes sp., 
Clostridium spp., Pasterella spp., Staphylococcus spp. and Streptococcus spp. (Scanlan, C.M., 
Hathock, 1983; Nagaraja and Lechtenberg, 2007). Interestingly, even Salmonella enterica, in 
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addition to F. necrophorum, has been cultured from abscesses originating from Holstein steers 
that had been on feed (Amachawadi and Nagaraja, 2015).   
F. necrophorum is part of the normal, healthy rumen flora and increases in concentration 
in the rumen when cattle are transitioned to a high grain, low roughage diet such as that fed 
during the finishing phase (Nagaraja et al., 1999b). When the ruminal epithelium is comprised, 
such as occurs during ruminal acidosis, F. necrophorum has the opportunity to inhabit the 
compromised rumen wall and eventually cross the epithelial barrier, entering the bloodstream. 
The bacteria travels through the portal vein and causes embolic showering to the liver. In the 
liver, the bacteria are able to utilize virulence factors to create a favorable environment for 
abscess formation. This pathologic process has been termed the rumenitis-liver abscess complex 
(Jensen, et al., 1954).  
This relationship between rumenitis and liver abscesses was first established in 1944 by 
H.A. Smith when a correlation was found between ruminal epithelial lesions and liver abscesses 
in cattle at the time of slaughter. At this time, Smith observed that of all cattle with rumen 
lesions, 42% had liver abscesses but only 9% of those with normal rumens had liver abscesses, 
and conversely, of all cattle with liver abscesses, 62% had rumen lesions. This hypothesis was 
further supported by Rezac et al. (2014) who noted that 32% of surveyed carcasses displaying 
mild or severe rumenitis also had liver abscesses but only 19% of carcasses with rumenitis had 
normal livers.  
Fusobacterium necrophorum is a non-motile, non-spore-forming, rod to pleomorphic 
shaped gram-negative bacteria (Langworth, 1977).  In cattle, F. necrophorum is associated with 
multiple common disease processes: liver abscesses, necrotic laryngitis (calf diphtheria), 
interdigital dermatitis (foot rot) and mastitis in cows (Nagaraja, et al., 2005). The bacteria uses 
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lactate as its major substrate, which is readily available in the rumen when cattle are on high 
grain rations such as most feedlot diets. High grain fed cattle have at least a 10-fold increase in 
F. necrophorum when compared to forage fed cattle (Berg and Scanlan, 1981). The bacteria 
normally reside in the rumen fluid, but can also be found adhered to the rumen wall (Narayanan, 
et al., 1998). When the rumen wall is compromised, it allows the bacteria to infect the damaged 
epithelium, causing rumenitis. This can happen in the case of ruminal acidosis, which is most 
commonly associated with liver abscesses, but it has also been hypothesized that other forms of 
rumen epithelial damage can include trauma from ingested foreign material, abrasive feedstuffs 
or even hair from self-grooming causing microabrasions (Fell et al., 1972).  
Fusobacterium necrophorum has a unique synergistic relationship with T. pyogenes, a 
gram-positive bacterium which is also a normal inhabitant of the rumen. Trueperella pyogenes is 
a facultative anaerobe and is often isolated in liver abscesses in addition to F. necrophorum, 
occurring in 2-20% of all abscesses where F. necrophorum is the primary agent (Nagaraja, et al., 
1996). Nagaraja et al., (1999a) found that T. pyogenes is more prevalent in abscesses isolated 
from cattle that received tylosin during the feeding period than those that did not (53 vs 10%), 
however the cause of this remains unknown.  
Fusobacterium necrophorum virulence factors include leukotoxin, endotoxin (LPS), and 
hemagglutinin (Tadepalli, et al., 2009). Leukotoxin appears to be the most important virulence 
factor, causing killing of bovine peripheral leukocytes through cellular activation and apoptosis 
in low concentrations and necrosis at high concentrations (Tan, et al., 1994, Narayanan et al., 
2002). The strains of F. necrophorum isolated in liver abscesses are more leukotoxic than those 
strains isolated from the rumen wall, implying that highly leukotoxic strains have an advantage 
in abscess formation (Tan, et al., 1994). Leukotoxin production has also been correlated to the 
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abscess formation in laboratory animals (Coyle-Dennis and Lauerman, 1979). Trueperella 
pyogenes is able to use Oxygen in the liver, creating an anaerobic environment for the F. 
necrophorum to thrive (Takeuchi, et al., 1983). Lactate, the primary substrate of F. necrophorum 
is an end product of T. pyogenes metabolism (Takeuchi, et al., 1983). They synergize by the 
virulence factors of F. necrophorum providing protection from phagocytosis to T. pyogenes, and 
T. pyogenes providing the substrate and anaerobic environment needed by F. necrophorum. A 
capsule is formed around the abscess, walling off the bacteria from the host’s defense system, 
allowing a more favorable environment for all bacteria (Lechtenberg, et al., 1988). 
Histologically, inside of the capsule, these abscesses are pyogranulomatous, containing an 
inflammatory area surrounding a necrotic core (Lechtenberg, et al., 1988).  
 Abscess Grading and Carcass Effects 
A modified Elanco liver abscess grading system (Elanco, Greenfield, IN) is commonly 
used to classify abscess severity. Often a 3 category system is used with classes being normal, A 
and A+. A common modification of this system is often used in research that adds an additional 
classification of A- for mild abscessation (Rezac et al., 2014). Normal livers are free of 
abscesses, scars, liver flukes, or any other pathology. Livers classified as A- have ≤ 2 abscesses 
and each abscess present is ≤ 2 cm in diameter. Livers showing resolved abscess scars but 
without active abscesses are also often classified as A-. Livers scored as A have 2 to 4 abscesses, 
each 2 to 4 cm in diameter. A+ livers have ≥ 4 abscesses or at least one abscesses that is ≥ 4 cm 
in diameter. Additional classifications often added include A+AD, when the liver is adhered to 
the diaphragm and/or body wall, and A+OP, where the abscesses are open, possibly 
contaminating other organs causing condemnation. 
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Liver abscess prevalence can vary widely, ranging from 0 to 80% in different studies 
(Amachawadi and Nagaraja, 2016). Many factors influence the prevalence of liver abscesses in a 
group including cattle factors, environmental factors, and management factors (Reinhardt and 
Hubbert, 2015, Amachawadi and Nagaraja, 2016). Liver abscess prevalence is slightly greater is 
steers than heifers (often 1 to 3% greater), which is believed to be due to a slightly elevated feed 
intake and the fact that heifers often mature earlier than steers, resulting in fewer required days 
on feed (Hicks, et al., 1990; Nagaraja and Lechtenberg, 2007). Holsteins have a much greater 
prevalence than beef cattle (often more than double the prevalence), and it is speculated that this 
is due to significantly increased time on feed and an elevated daily feed intake (Hicks, et al., 
1990; Nagaraja and Lechtenberg, 2007; Amachawadi and Nagaraja, 2016). Grooming behavior 
may also contribute to liver abscess prevalence, as Holsteins have been observed to groom 
themselves and penmates more than beef cattle (Fell, et al., 1972). Liver abscesses are seen most 
commonly in the Plains states than other regions of the US including the Northwest, Southwest, 
and Midwest (Reinhardt and Hubbert, 2015). The reason for this geographic difference is 
unknown but is speculated to be affected by ration differences and possibly different strains of F. 
necrophorum endemic to different soil types. In fact, the majority of feedlots in regions where 
cattle have lower liver abscess rates (those in the Northwest, Southwest, and Midwest) do not 
need to include tylosin in the diet of their finishing cattle.  
The 2016 National Beef Quality Audit recorded 17.8% of the fed cattle observed at 
abattoirs had liver abscesses, contributing to a 30.8% liver condemnation rate (Eastwood, et al., 
2017). Other common liver defects seen at slaughter include liver flukes (also referred to as 
distoma), cirrhosis and telangiectasis. Livers are commonly condemned due to contamination at 
slaughter, this can be from a ruptured liver abscess or condemnation from other organs such as 
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rumen contents. This percentage of liver abscesses in fed cattle is increased when compared to 
the last 15 years of Beef Quality Audits. In 2010, 13.7% of observed livers contained 
abscessation, in 2005, 13.4%, and in 2000, 13.6% (McKenna, et al., 2002; Garcia, et al., 2008, 
McKeith, et al., 2012). This increase could be due to an increase in the percentage of cattle on 
“natural” programs which restrict the use of hormones and antibiotics during the finishing 
period, so these cattle never receive tylosin.  
Liver abscesses can cause significant economic loss during the finishing period and at 
slaughter (Brink, et al., 1990; Brown and Lawrence, 2010). Brink, et al. (1990) analyzed data 
from 12 different experiments in which animals were individually fed. Variables that differed 
between normal livers and those with A+ scored livers included end weights, HCW, dressing 
percentage and feed intake, all tending to be less for steers with abscessed livers than their 
counterparts with normal appearing livers. These losses include decreased HCW, ribeye area, 
marbling scores for cattle (Brown and Lawrence, 2010). Brown and Lawrence (2010) also found 
that the greatest economic losses associated with liver abscesses are those carcasses with livers 
scoring A+, especially those livers that are adhered to the diaphragm, abdominal organs, or body 
cavity. When the abscesses are adhered to the body cavity, these areas have to be cut away from 
the carcass, increasing trim loss. This estimated trim loss ranges from 3 to 13.2 kg in different 
studies (Davis et al., 2007; Brown and Lawrence, 2010). It has been estimated that severe liver 
abscesses can decrease the value of an affected carcass by $38 (Brown and Lawrence, 2010), to 
more than $52 (Reinhardt and Hubbert, 2015), however due to cattle market fluctuations, this 
value could be even higher today.  
While the effects of liver abscesses on feedlot performance and carcass characteristics 
has been well documented, the effects of liver abscesses on meat tenderness within quality grade 
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had not been investigated before this author’s study (McCoy et al., 2017). Animal health during 
the finishing phase can greatly worsen feedlot performance, decrease both quality and yield 
grade, and even decrease meat tenderness within quality grade (Gardner et al., 1999). Gardner et 
al., (1999) fed cattle in a commercial feedlot for 150 days and monitored cattle for clinical signs 
of respiratory disease daily and lung lesions at the abattoir. Shear force values were analyzed on 
Longissimus steaks and were found to be lower in steaks from cattle without lung lesions when 
compared to those with active lesions at the time of slaughter (3.6 vs 4.0 kg). McCoy et al., 
(2017) investigated the effects of liver abscess severity on meat tenderness assays and sensory 
attributes in cattle finished at a commercial feedlot on a diet that did not contain tylosin 
phosphate. This study reported that liver abscess status had no effect on Warner-Braztler Shear 
Force or Slice Shear Force but in sensory analysis, quality grade Select steaks from cattle with 
moderate liver abscesses were found to have greater myofibril tenderness than those with severe 
liver abscesses (P < 0.03). The results of this study indicate that liver abscesses do not have an 
impact on meat tenderness as measured by WBSF or SSF and do not impact beef juiciness or 
flavor attributes but may impact the myofibril tenderness of quality grade Select beef. This was 
an important finding as the beef industry may soon be faced with the task of reducing antibiotic 
use, specifically tylosin, and in turn, increasing liver abscesses in our fed cattle population if an 
effective alternative prevention technique is not identified soon. If this occurs, McCoy et al. 
demonstrated that consumers will not have a decreased eating experience due to liver abscesses 
other than the decrease in quality grade, which consumers are aware of when making a 
purchasing decision. 
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 Tylosin 
Macrolide antbiotics such as tylosin phosphate have proven effective at decreasing the 
concentration of F. necrophorum in the rumen and in turn decreasing liver abscesses. Nagaraja, 
et al. (1999b) showed a decrease in ruminal F. necrophorum levels when adding tylosin 
phosphate at the approved label dose (90 mg/hd/d) to an 80% concentrate diet in ruminally 
cannulated animals. This study found that feeding tylosin had no effect on ruminal fermentation 
products including pH, VFAs, lactate, or ammonia. Continuous feeding of tylosin did reduce F. 
necrophorum levels further over time during the 31 day feeding period suggesting continued 
susceptibility to the antibiotic and results suggested that the number of resistant bacteria did not 
increase over time.  
Tylson has been shown to reduce the prevalence of liver abscesses by up to 81.8% in 
large pen studies (Brown, et al., 1973, Brown et al, 1975). Both tylosin phosphate and tylosin 
urea adduct have been shown to be effective at reducing liver abscesses however Tylan, the 
macrolide on the market today labeled for reduction of liver abscesses is in the form of tylosin 
phosphate (Brown, et al., 1973). Both forms of tylosin were found to reduce the incidence of 
liver abscesses and in turn increase average daily gain, and improve feed conversion in the initial 
study by Eli Lilly and Company (Brown, et al., 1973). Brown et al. (1975) compared tylosin and 
chlortetracycline and found that both reduced the incidence of liver abscesses compared to 
control cattle, however tylosin produced a greater reduction in abscesses.  
Nagaraja et al., (1999a) cultured F. necrophorum and T. pyogenes from liver abscesses 
originating from cattle that had received tylosin and a group that had not. This study found no 
difference between the isolates from these two groups for the MIC of tylosin, chlortetracycline, 
oxytetracylcine, tilmicosin, virginiamycin, bacitracin, lasalocid, or monenin. These results 
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indicate that the use of tylosin does not cause resistance of these 2 species of bacteria to the 
tested antimicrobial compounds. However, this study did not investigate the effects of daily 
tylosin administration on antibiotic resistance in other species of bacteria in the rumen. 
In a small pen study, Muller et al. (2018) intermittently fed tylosin, feeding it off label at 
1 week on, 2 weeks off and compared it to cattle fed without tylosin, and a group fed tylosin 
continuously during the finishing period (119 days). There was no difference in liver abscess 
prevalence between the group receiving continuous and intermittent tylosin (7.84 vs 9.62%), 
however they both differed from the group receiving no tylosin (21.36%). Muller et al. (2019) 
also concluded that Enterococcus bacterial counts didn’t differ between groups but all groups 
developed macrolide resistance in the Enterococcus bacteria over time. These authors concluded 
that macrolide resistance develops not because of macrolide administration to the cattle of 
interest but instead is acquired through the environment that has developed due to long term 
antibiotic usage.  Results from this study indicate that intermittent feeding of tylosin can reduce 
the overall total use of antimicrobials by feedlots without compromising liver abscess prevention 
and will not likely cause additional macrolide antibiotic resistance issues over those caused by 
daily tylosin administration.  
 Regulatory Concerns 
A concern with antimicrobial use in food animals is the potential contribution to 
antimicrobial resistance in both veterinary and human medicine. Macrolide antibiotics, the class 
of antibiotics to which tylosin belongs, are considered a critically important drug class in human 
medicine (FDA, 2003). In 2012, the U.S. Food and Drug Administration (FDA) issued guidance 
209, a document intended to provide guidance to the food animal industry on the use of 
medically important antibiotics to human medicine and their use in food-producing animals. This 
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document outlined two main principles including limiting the use of medically important 
antimicrobial drugs in food animals to those necessary to assure animal health, therefore 
discouraging the use of these drugs for growth promotion purposes, and ensuring that these 
medications are only used in food animals under the direction of a veterinarian. In 2013, 
guidance 213 was published, re-emphasizing the information in guidance 209 and outlining a 
timeline for the transition of these drugs from over-the-counter status to prescription or 
Veterinary Feed Directive Status. At this time, it was also requested of the food animal industry 
to voluntarily phase out medically important antimicrobials being used for production purposes. 
The Veterinary Feed Directive (VFD) final rule came into effect in 2017 and at this time it was 
federally mandated that all medically important antibiotics administered through food and water 
to food producing animals had to be under the written supervision of a veterinarian in accordance 
with all label directions, which could no longer include any growth promotion claims. For the 
purpose of this paper, these documents federally regulated tylosin, mandating that it can only be 
administered according to label directions, including dosages, under the written direction of a 
veterinarian. 
There is some speculation that antimicrobials considered medically important to human 
medicine will become increasingly regulated in food animal species and this could increase liver 
abscess incidence in feedlot cattle. The industry is actively searching for an alternative solution 
to the use of daily in-feed antibiotics to prevent this animal welfare and economic concern. 
Below is discussion of methods of non-antibiotic liver abscess prevention that have been 
researched including vaccination against the causative agents, feed additives such as essential 
oils, and a brief review of the impact of diet on liver abscesses.  
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 Vaccines 
Vaccination against F. necrophorum and T. pyogenes has been a widely researched as a 
liver abscess prevention technique. If a vaccine was available that was as efficacious as tylosin, 
feedlot antimicrobial use would be significantly reduced and it could be competitively priced 
when compared to daily tylosin administration. Vaccines are also allowed to be administered in 
cattle fed as part of “natural” programs, a market that currently has no commercially available 
liver abscess prevention tools.  
Leukotoxin has been heavily investigated as a potential vaccine component (Tan et al., 
1994b; Saginala, et al., 1996; Saginala et al., 1997). The virulence of leukotoxin combined with 
the high molecular weight (>300,000) of the protein make it a highly immunogenic compound 
(Narayanan, et al., 2002). Anti-leukotoxin antibody titers have been shown to correlate to 
severity of liver abscesses, those animals with higher antibody titers producing less severe 
abscesses (Tan et al., 1994). Sanginala et al. (1996) developed experimental vaccines against F. 
necrophorum subsp. necrophorum with 3 different antigen types including a inactivated whole-
cell culture, a crude leukotoxin, and a semipurified leukotoxin used in combination with Saponin 
and oil emulsion adjuvants. Cattle were inoculated intraportally with F. necrophorum and serial 
serum antibody levels were measured. The culture supernatant produced increased titers of 
serum leukotoxin-neutralizing antibody, IgG and IgM in vaccinated cattle. As a follow up to this 
study, Sanginala et al. (1997) investigated this vaccine containing a cell-free culture supernatant 
of a high leukotoxin-producing strain of F. necrophorum that had been inactivated combined 
with an adjuvant. This product was used in 3 different doses (1, 2, and 5 mL) with 2 doses being 
administered, 21 days apart. Twenty one days following the revaccination, the F. necrophorum 
culture was injected intraportally to experimentally induce liver abscesses. Antileukotoxin 
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antibody titers did develop in a dose-dependent fashion and were found to be higher in steers that 
did not develop abscesses when compared to those that did. The results of this study indicated 
that vaccination against F. necrophorum using a leukotoxin antigen could reduce liver abscess 
incidence and severity.  
Jones et al., (2004) conducted two studies at a commercial feedlot investigating a T. 
pyogenes - F. necrophorum bivalent bacterin-toxoid vaccine administered as a single dose 
product. The vaccine contained an inactivated F. necrophorum leukotoxin and T. pyogenes 
pyolysin that was used in combination with a water-in-oil adjuvant. Two antigen levels were 
used, and the high antigen containing vaccine was found to be effective, reduce liver abscess 
prevalence by 37.5 to 48.4% (16% vaccinates vs 31% controls in study one and 30% vaccinates 
vs 48% controls in study two) in cattle on a high grain ration. This product was later 
commercially available as Centurion, first produced by Schering-Plough Corp, now Merck 
Animal Health (Omaha, NE). Centurion was labeled to “aid in the reduction of liver abscesses” 
and is no longer commercially available. 
 Fusogard (Elanco Animal Health US, Inc, Greenfield, IN) is a F. necrophorum bacterin 
vaccine labeled to “aid in the reduction of clinical signs of footrot and the number and size of 
liver abscesses caused by F. necrophorum”. This product is still currently on the market, and 
used in some feedlots, primarily due to the footrot prevention benefits. Fusogard has been shown 
to be effective in groups of cattle with low overall prevalence of liver abscesses (decreasing 
overall abscesses from 10% to 2%), but is less effective in groups of cattle with an increased 
overall prevalence (decreasing abscesses from 30% to 24%) (Checkley, et al., 2005). In a 
comparative study of Centurion and Fusogard with a negative control, Fox et al. (2009) found 
that neither vaccine reduced liver abscess prevalence nor severity in a group of cattle that had 
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high liver abscesses prevalence (56% total abscess prevalence, 39% severe). This author 
conducted research using an autogenous vaccine against F. necrophorum in an attempt to reduce 
the prevalence of liver abscesses seen at slaughter, however this vaccine was not found to reduce 
liver abscesses in natural fed cattle in a large pen trial. This data can be found in chapter 3 of this 
dissertation. 
To summarize these findings, vaccination may be sufficient as a prevention approach in 
groups of cattle with low liver abscess incidence or when used in combination with other 
management strategies and prevention methods. Currently there are no vaccines on the market 
that are effective at reducing liver abscess prevalence or severity in groups of cattle with high 
prevalence. This may change in the future as this is an area where many research efforts have 
been focused.  
 Feed Additives  
Essential oils have been used experimentally attempting to reduce liver abscesses by 
reducing the amount of F. necrophorum in the rumen. Essential oils are natural chemical 
compounds derived from plants that have been used for a variety of purposes, including their 
potential as antimicrobials. The antimicrobial properties of essential oils have been widely 
studied and their mechanism of action is attributed to the disintegration of the bacterial cell 
membrane (Helander, et al., 1998; Hammer, et al., 1999). In vitro, limonene, at 20 or 100 µg/mL, 
and thymol 100 µg/mL inhibit F. necrophorum growth, however eugenol, guaiacol, and vanilla 
did not inhibit F. necrophorum growth (Elwakeel, et al., 2013). In contrast, Samii., et al. (2016) 
found that both limonene linear and quadratically reduced F. necrophorum growth in-vitro at 
concentrations up to 100 µg/mL but did not completely inhibit growth as previously found. This 
study also found that thymol linearly reduced F. necrophorum growth in-vitro at concentrations 
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up to 100 µg/mL but showed less of an effect than limonene. Samii, et al. (2016) also noted that 
there was no synergistic effect between limonene and thymol in-vitro.  
 In ruminally cannulated animals limonene decreased ruminal concentrations of F. 
necrophorum (Samii., et al., 2016). This study found that 40 mg/kg of limonene was most effect 
at decreasing F. necrophorum concentrations, decreasing from 2.65 log10 in the control animals 
to 2.15 log10 in the 40 mg/kg treatment group. The authors acknowledged that although a 
decrease in ruminal F. necrophorum concentrations occurred, this may not reduce liver abscess 
prevalence due to the relatively small magnitude of reduction and the killing of F. necrophorum 
in the rumen fluid versus those adhered to the rumen epithelium. The effects of thymol was not 
investigated in-vivo in this study.   
Active yeast products have been used in feedlot rations and are proposed to impact rumen 
health and in turn liver abscesses. Ran et al. (2018) investigated supplementing a finishing diet 
with an active dried yeast product in two forms- ruminally protected and non-protected. Non 
ruminally protected active dried yeast and a mixture of the protected and non-protected active 
dried yeast products both decreased severely abscessed livers seen at slaughter compared to 
those cattle receiving no antibiotics, those receiving monensin and tylosin, and those receiving 
only a protected active dried yeast product. Overall liver abscess prevalence did not differ 
between the treatment groups. These results imply that the yeast works at the level of the rumen, 
possibly altering rumen microflora. Interestingly, cattle receiving the yeast product in either form 
also tended to have lower fecal Eschericial coli counts compared to both the control group and 
the group receiving tylosin and monensin.  
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 Roughage 
Roughage levels in the finishing ration is assumed to play a key role in liver abscess 
formation due to its influence on rumen pH, subsequent acidosis and rumenitis. Increasing 
roughage during the finishing period has proven effective at decreasing the prevalence of liver 
abscesses in rations containing many different grain and roughage sources (Brent, 1976; Zinn 
and Plascencia, 1996; Loerch and Fluharty, 1998). This is a vast area of research in ruminant 
nutrition and will only be briefly discussed here.  
Zinn and Plascencia (1996) found that increasing alfalfa level in a feedlot ration from 10 
to 30% decreased liver abscess prevalence by 86% at the time of slaughter following a 135 day 
feeding period (15.2 vs 2.1%). Loerchy and Fluharty (1998) added corn silage as a roughage 
source to a concentrate diet for the last 102 days of feeding period with treatment groups 
receiving a 100% concentrate diet or a group receiving an 85% concentrate and 15% corn silage. 
Those cattle receiving 15% roughage had fewer abscessed livers seen at the time of slaughter 
than those cattle receiving only concentrate (14.7% vs 29.3%).  
Bartle et al. (1994) showed that increasing roughage from 2% to 10% in 2 different 
rations, one containing steam-flaked sorghum and one with whole-shelled corn for the last 28 
days of the finishing period can reduce liver abscess prevalence (9% vs 0% in the sorghum diet 
and 6% vs 0% with whole-shelled corn diet). It is proposed that this allows time for the liver 
abscesses that have formed during the finishing period to heal before the cattle are sent to 
slaughter. Loerch and Fluharty (1998) found that cattle receiving a 100% concentrate diet for the 
first 84 days but were then switched to a 85% concentrate, 15% roughage (corn silage) diet for 
the last 102 days of the feeding period did not differ in liver abscess prevalence at slaughter 
compared to those that were receiving 15% roughage for the entire 186 day feeding period. Both 
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of these groups had lower liver abscesses when compared to treatment groups receiving 100% 
concentrate rations for the entire feeding period, or only the last 102 days of the feeding period. 
Those cattle receiving a 100% concentrate ration for the entire 186 day feeding period did have a 
higher overall gain/feed ratio than those cattle receiving a 85% concentrate for the entire period 
(0.192 vs 0.174 kg), however neither of these groups differed statistically for this variable from 
either of the two groups, those switched from the 100% ration to the 85% ration on day 84 or the 
group that switched from the 85% to 100% ration on day 84. Reinhardt and Hubbert (2015) state 
that roughage is a costly ration ingredient on a per-unit-of-net-energy basis and can be costly and 
difficult to handle. Increasing roughage during the end of the feeding period would mitigate 
these issues, however animal welfare concerns are still applicable as cattle would still have the 
opportunity to form abscesses early in the feeding period and would just be given an opportunity 
to heal.  
Interestingly, not only roughage level, but also the form of roughage in the ration appears 
to have an impact on the prevalence of liver abscesses. Calderon-Cortes and Zinn (1996) fed a 
steam-flaked corn based diet with a roughage source of alfalfa hay chopped at 2 stem lengths and 
fed at 3 different inclusion rates, 0, 8, and 16%. This study found that fiber coarseness, and not 
roughage level influenced liver abscesses with finer alfalfa producing 12.5% abscesses vs 0% 
abscesses with courser alfalfa in the 8% alfalfa ration. Utley et al. (1973) found that cattle fed a 
ground corn based diet with 20% whole peanut hulls had fewer liver abscesses than if these 
peanut hulls were ground or pelleted (4% vs 52% and 59%). These results indicate that the 
stimulation of the roughage on the rumen wall may impact rumen health and decrease liver 
abscess formation and that roughage inclusion is not only beneficial due to the energy dilution 
effects.  
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 Conclusion 
Liver abscesses continue to be a persistent problem for the US cattle feeding industry and 
may even increase in concern as the federal regulation of antimicrobial use in food producing 
animals increases. While tylosin phosphate has been successful at reducing liver abscesses, 
alternatives are actively being researched to help reduce antibacterial use in food animals. The 
causative against F. necrophorum, which synergizes with T. pyogenes, has been a target for 
vaccine development for many years. Vaccination has been shown to be successful at liver 
abscess prevalence and severity reduction in cattle with relatively low prevalence of liver 
abscesses. Therefore, vaccination used in combination with other methods to reduce liver 
abscesses but does not decrease liver abscess prevalence in groups of cattle with high prevalence. 
This dissertation contains research on a new vaccine, which is an autogenous vaccine against F. 
necrophorum including a novel adjuvant that had been successfully used in other vaccines. It is 
possible that vaccination in combination with increased roughage levels or a change in roughage 
source could have an increased reduction in liver abscesses, challenging the current reduction 
levels seen with tylosin, therefore negating the need for antibiotics to prevent this disease. 
Essential oil compounds, particularly limonene show potential to reduce liver abscesses when 
included in feedlot rations, but more research is needed on this topic. Active yeast products may 
reduce severity of abscesses but have not been shown to decrease overall liver abscess 
prevalence. Increased roughage in the ration, even if only for the last 28 days of the feeding 
period and the feeding of course roughage sources can decrease abscesses seen at the time of 
slaughter. Liver abscesses are truly a disease at the junction of animal health and nutrition. The 
veterinary and nutrition communities must work together to find an alternative to antibiotic use 
to decrease liver abscesses in the feedlot industry moving forward.  
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Chapter 2 - Effects of liver abscess severity and quality grade on 
meat tenderness and sensory attributes in commercially finished 
beef cattle fed without tylosin phosphate 
 Abstract 
Strip loin steaks (n = 119) were used to evaluate the effects of liver abscess severity and 
USDA quality grade on meat tenderness and sensory attributes of steaks from finished feedlot 
cattle. Steaks were used in a 3 × 2 factorial treatment structure using a completely randomized 
design and were collected at a commercial abattoir located in northwest Texas. All cattle were 
sourced from a single feedlot and fed a common diet that did not include tylosin phosphate. 
Treatments were USDA quality grades of Select (S) and Low Choice (C) and liver abscess 
scores of normal (N; healthy liver with no abscesses), mild (M; 1 abscess less than 2 cm in 
diameter to 4 abscesses less than 4 cm in diameter), and severe (SV; 1 abscess greater than 4 cm 
in diameter or greater than 4 small abscesses). All steak samples were collected on the same day 
and were cut from the left side of the carcass at the 13th-rib by a trained abattoir employee. 
Steaks were vacuum-packaged, and aged at 3 ± 1o C for 14-d post-mortem. Warner-Braztler 
Shear Force (WBSF) and Slice Shear Force (SSF) analyses were conducted and cook-loss 
percentage was measured. A trained sensory panel analyzed samples for juiciness, tenderness, 
and flavor attributes. There were no differences among liver abscess scores for WBSF or SSF (P 
> 0.52). Warner-Bratzler Shear Force was lower for C-SV than S-SV (P = 0.04). Sensory 
attributes of initial and sustained juiciness, and overall tenderness were all greater for C than for 
S steaks (P < 0.04) and connective tissue amount was less for C steaks when compared to S (P = 
0.03). Liver abscess score had no effect on any sensory attributes (P > 0.70); however, there was 
28 
 
 
 
an interaction between quality grade and liver score for myofibillar tenderness (P = 0.03). Within 
C steaks, liver abscess score had no effect on myofibrillar tenderness (P > 0.05), however, in S 
steaks, M steaks were more tender than SV steaks (P < 0.03). 
These results indicate that within quality grades, meat tenderness or sensory attributes 
were not influenced by liver abscess score but that M liver abscesses may affect the myofibrillar 
tenderness of S steaks. 
Key words: cattle, feedlot, liver abscesses, meat tenderness, palatability, quality grade 
 Introduction  
Liver abscesses are a significant problem in the United States’ cattle feeding industry, 
costing the industry an estimated $15.9 million annually in liver condemnation, trim losses, and 
reduced carcass weights and quality grades (Brown and Lawrence, 2010; Hicks, 2011). The 2011 
National Beef Quality Audit reported the average prevalence of liver abscesses in cattle surveyed 
was 13.7% (McKeith et al., 2012) with incidence rates ranging from 10 to 20% in recent 
literature (Amachawadi and Nagaraja, 2016). Previous reviews have reported liver abscess 
incidence is influenced by a number of factors including: breed, gender, diet, days on feed, cattle 
type, season, and geographical location (Nagaraja et al., 1996; Reinhardt and Hubbert, 2015). 
Liver abscesses occur subsequently to rumen insults caused by acidosis and rumenitis, 
often referred to as the “rumenitis-liver abscess complex” (Jensen et al., 1954). Cattle fed 
readily-fermentable concentrate-based diets often have lower rumen pH levels that have the 
potential to cause damage to ruminal epithelium tissue (Haskins et al., 1969). It has been 
proposed that pathogens associated with liver abscess formation enter the blood stream through 
perforated rumen epithelium and are transported to the liver through the portal vein (Smith, 
1944; Nagaraja and Chengappa, 1998).  
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Brown and Lawrence (2010) showed a reduction in HCW, dressing percentage, yield 
grade, LM area, and marbling scores for carcasses with multiple large abscesses and decreased 
marbling scores for severe liver abscesses with adhesions when compared to their counterparts 
with normal livers. Although the effect on carcass characteristics has been researched, no 
previous work has evaluated the effect of liver abscess status on meat tenderness and sensory 
attributes. Therefore the objective of this study was to determine the effects of liver abscess 
severity on meat tenderness and sensory attributes of steaks from USDA Low Choice and Select 
quality grades. 
 Materials and methods 
Institutional Animal Care and Use Committee approval was not required for this study 
because no live animals were handled. The protocols for the use of human subjects for this study 
were reviewed and approved by the Kansas State University Institutional Review Board (IRB 
#7440). 
Carcasses: 
For this study, Bos Taurus steers originated from the same commercial feedlot and were 
fed common diets that did not contain tylosin phosphate. All carcasses utilized in this study were 
from cattle that were slaughtered on a single day at a commercial abattoir in northwest Texas and 
carcasses were selected after lungs and livers were scored. Only carcasses with healthy, normal 
lung scores were utilized to avoid any potential effects on tenderness or sensory attributes caused 
by respiratory disease.  
Liver Scores: 
Liver scores were evaluated and recorded by trained observers at harvest using the 
scoring system previously defined by Rezac, et al. (2014). Livers were scored as 0 (no 
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abscesses); A- (1 to 2 abscesses less than 2 cm in diameter); A (2 to 4 abscesses between 2 and 4 
cm in diameter); A+ (1 abscess greater than 4 cm in diameter or greater than 4 small abscesses); 
and A+/AD (A+ criteria with adhesions to the body cavity; Rezac et al., 2014).  For this study, 0 
represented the normal (N) liver population, A- and A represented the mild (M) liver abscess 
population, and A+ and A+ with adhesions represented the severe (SV) liver abscess population. 
At the time of liver scoring, carcasses were given a sequence number that was then correlated 
back to the plant identification number.   
Steak Collection:  
Quality grades of USDA Low Choice (C) and Select (S) and liver abscess scores of N, M, 
and SV were used for this study. Carcasses were chilled at the abattoir for approximately 36 h 
postmortem before grading. USDA quality grades were assigned to carcasses at the grading stand 
and carcass tags were used to identify carcasses in each treatment category. Colored tags were 
placed onto the carcasses of interest and they were railed off for steaks to be collected. Strip loin 
steaks were cut approximately 6.35 cm thick from the left side of the carcass at the 13th rib by a 
trained abattoir employee the same day they were graded. Steaks from a total of 119 carcasses 
were collected and consisted of the following: 22 C-N; 20 C-M; 20 C-SV; 21 S-N; 20 S-M; and 
16 S-SV. Steaks were put into labeled Ziploc freezer bags and put on ice to be transported back 
to Manhattan, KS, where steaks were vacuum-packaged and aged at 3 ± 1o C for 14 d 
postmortem. Steaks were stored for 48 h at –20o C then faced and cut into two 2.54 cm steaks 
using a band saw (BIRO Model 3334; BIRO Manufacturing Company, Marblehead, OH). The 
more anterior steak was used for sensory panel and the more posterior steak was used for 
instrumental tenderness measures.  
Shear Force Measurements: 
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Laboratory assays were conducted at the Kansas State University Meat Laboratory 
(Manhattan, Kansas). Warner-Bratzler Shear Force (WBSF) and Slice Shear Force (SSF) were 
conducted according to the American Meat Science Association (AMSA) Research Guidelines 
for cookery, sensory evaluation, and instrumental tenderness measurements of meat (AMSA, 
2015). Steaks were randomized using a random number generator and thawed for 24 h at 3o C. 
Steaks were weighed before and after cooking to calculate cook-loss. Before cooking, a 30 gauge 
copper/constantan thermocouple was inserted into the geometric center of each steak. Steaks 
were cooked on clamshell grills (Cuisinart Griddler, East Windsor, NJ) set to 176.7o C that had 
been sprayed with nonstick cooking spray. Internal temperatures were monitored with a Doric 
Minitrend 205 monitor (VAS Engineering, San Francisco, CA). Steaks were removed from the 
grill when an internal temperature of 65.6o C was reached for a target endpoint temperature of 
70o C. Once maximum rise in temperature was reached, thermocouples were removed and steaks 
were cut for SSF using a SSF kit (G-R Elec. Mfg., Manhattan, KS). An Instron testing machine 
(Model 5569; Instron, Canton, MA) was used in combination with a SSF blade (crosshead speed 
of 500 mm/min). After SSF, the remaining portion of the steak was cooled overnight at 3o C and 
used for WBSF. Six 1.27 cm cores, parallel to the muscle fiber orientation, were removed and 
sheared on the Instron testing machine with a v-blade (crosshead speed of 250 mm/min) for 
WBSF analysis. The values of the 6 cores were averaged to obtain a single WBSF value for each 
steak.  
Sensory Analysis: 
Panelists were trained over a series of training sessions with a minimum number of 3 
trainings attended over a 5 d period with a 2 d period between the end of trainings and the 
beginning of panels. Characteristics on which panelists were trained included initial juiciness, 
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sustained juiciness, myofibrillar tenderness, connective tissue, overall tenderness, beef flavor 
intensity, and off-flavor intensity. Anchors described by Adhikara et al. (2011) were provided at 
each training session and were used to set the 100 point beef flavor intensity scale. Sensory 
scales ranged from 0 to 100 with 0 being extremely dry, tough, none, or bland, 50 being neither 
dry nor juicy, neither tough nor tender, and 100 being extremely juicy, tender, abundant, or 
intense.  
Steak samples for sensory analysis were stratified by liver score and USDA quality grade 
and randomly assigned to one of 20 sensory panels so that each panel had one steak from each 
treatment combination. Six samples were evaluated per panel with a maximum of two panels per 
day. Steaks were prepared in the same manner as described above for WBSF and SSF.          
Immediately after peak temperature was reached, steaks were cut into uniform 1.3 × 1.3 × 
2.5 cm cubes using a Sensory Evaluation Box (G-R Elec. Mfg., Manhattan, KS) and placed into 
a metal double boiler to remain warm until served. Panels consisted of 20 sessions with 7 to 9 
trained panelists per session. Panelists were seated in individual sensory analysis booths lit with 
low-intensity red and green incandescent light to mask any color differences. Unsalted crackers, 
apples, and deionized, distilled water were provided as palette cleansers. Digital tablet computers 
were used to record sensory data on each steak with each category having a continuous line scale 
from 0 to 100. Qualtrics analytics software (Qualtrics 2015, Version 2417833, Provo, UT) was 
used to record and summarize data.  
Statistical Analysis:  
Sensory panel, WBSF, and SSF data were analyzed using the GLIMMIX procedures of 
SAS (version 9.4; SAS Inst. Inc., Carry, NC). Sensory panel data were averaged within each 
steak and averages were used for analysis. Quality grade, liver score, and their interaction were 
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analyzed as fixed effects and panel number was used as a random effect. Warner-Bratzler Shear 
Force and SSF data were analyzed with quality grade, liver score, and their interaction as fixed 
effects, and off peak temperature used as a covariate. A Kenward-Roger adjustment was applied 
to the degrees of freedom for all analyses. Significance was determined at P < 0.05.  
 Results 
Sensory Panel: 
Results for sensory panel data can be found in Table 2.1. There were no interactions for 
any combination of grade × liver score for initial juiciness, sustained juiciness, connective tissue 
amount, overall tenderness, beef flavor intensity, off flavor intensity or cook loss (P ≥ 0.06).              
There was a quality grade effect for initial juiciness, sustained juiciness, connective tissue 
amount, overall tenderness, and beef flavor intensity (P < 0.05). As expected, C steaks were 
greater (P < 0.02) for initial and sustained juiciness compared to S. Liver abscess score had no 
effect (P > 0.70) on initial or sustained juiciness.  
There was a quality grade × liver score interaction for myofibrillar tenderness (P = 0.03). 
Within C steaks, liver abscess score had no effect on myofibrillar tenderness (P > 0.05), 
however, within S steaks, M steaks were more tender than SE steaks (P < 0.03; Figure 2.1).   
Select steaks had a greater (P < 0.04) amount of connective tissue than C. Liver abscess 
status had no effect (P > 0.70) on connective tissue amount among N, M, or SV treatments. Liver 
abscess score had no effect (P = 0.79) on overall tenderness.  
For beef flavor intensity and off flavor intensity, neither quality grade nor liver abscesses 
scores differed (P > 0.26).  
Warner-Bratzler Shear Force and Slice Shear Force 
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Warner-Bratzler Shear Force and SSF data is presented in Table 2.1. There was no 
quality grade × liver score interaction for WBSF values (P = 0.38). Neither quality grade nor 
liver score affected (P > 0.08) WBSF values. There was no interaction for quality grade × liver 
score for SSF values (P = 0.61). Slice Shear Force was not affected by quality grade or liver 
score (P > 0.38). Cook loss was not affected (P > 0.20) by quality grade or liver score. 
 Discussion 
Liver abscesses are a concern in the beef industry as an economic loss to feedlots and 
abattoirs in addition to a possible animal welfare concern, specifically with severe abscesses 
(Reinhardt and Hubbert, 2015). Liver abscesses can decrease value of beef carcasses by up to 
$38 per animal (Brown and Lawrence, 2010). All liver abnormalities are estimated to cost the 
industry more than $15 million annually in lost liver value alone, with 67% of these 
abnormalities being liver abscesses (Brown and Lawrence, 2010). According to the 2011 
National Beef Quality Audit liver condemnation had an incidence rate of 20.9% with 5.4% being 
condemned for major abscesses, 8.3% due to minor abscesses, and the remainder being for 
flukes, contamination, or other reasons (McKeith et al., 2013).  Fortunately, results from this 
study indicate that liver abscesses do not effect meat tenderness or sensory attributes within C 
and S quality grades.  
Carcasses selected for this study were selected to have normal lungs with no 
consolidation. When liver abscesses rupture at the abattoir, all offal affected is condemned. 
When this occurred during this study’s data collection, lungs were not able to be scored and 
therefore these carcasses were not included in this study. Consequently, a portion of the carcass 
population with SV liver abscesses were not eligible for this study.  
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Product consistency is important to ensure consumer satisfaction, therefore it is necessary 
to understand the effect of live animal traits on meat tenderness. Beef tenderness has been 
identified as one of the most important buying considerations to consumers (Lusk et al., 2001, 
Savell et. al., 1987); however, there is much unexplained variation in beef tenderness within 
USDA quality grades (Smith et al., 1986). It has been well documented that chronic health 
problems such as bovine respiratory disease and SV liver abscesses can decrease beef yield and 
quality grades (Brown and Lawrence, 2010, Gardner et al., 1999). However, there is limited 
reported research evaluating the effects of liver abscesses or disease status on meat tenderness 
and sensory attributes. Gardner et al. (1999) reported no differences in WBSF values of LM 
steaks from animals with respiratory tract lesions at slaughter compared to animals without 
respiratory tract lesions when steaks had been aged for 14 or 21 d. However, a difference in 
tenderness at 7 d of aging was reported, with carcasses from animals with active respiratory tract 
lesions having higher WBSF values when compared to their normal counterparts, 4.0 and 3.6 kg 
respectively, but the authors indicated this difference was likely due to marbling differences 
within USDA quality grades between the groups. It is unknown why this tenderness difference 
was only observed at d 7 and not at later time points. Many studies have shown that steak 
tenderness increases as postmortem aging periods increase (Eilers et al., 1996, Lepper-Blilie et 
al., 2015, Martin et al., 1971). Currently, there is no standard amount of time that beef is aged 
postmortem before consumption, however the 2010 National Beef Tenderness Survey found that 
21.6 d was the average post-fabrication aging period for strip loins at retail establishments before 
consumer purchase (Guelker et al., 2013).  
Brown and Lawrence (2010) reported decreased 12th-rib fat depth for all liver abscess 
scores compared to healthy counterparts, along with decreased HCW yield grade, and marbling 
36 
 
 
 
scores associated with SV liver abscesses. The results of this study and those found by Gardner 
et al. (1999) and Brown and Lawrence (2010) imply that infections such as respiratory disease 
and liver abscesses negatively affect carcass characteristics such as HCW and marbling scores, 
but have no effect on meat tenderness or sensory attributes.  
A linear increase of beef tenderness has been shown with increasing USDA quality 
grades (McBee and Wiles, 1967; Guelker et al., 2013). The 2010 National Beef Tenderness 
Survey found that overall, S steaks had greater WBSF values than C steaks, but data specifically 
for strip loin steaks was not reported (Guelker et al., 2013). While this research did not find an 
increase in tenderness, as measured by WBSF and SSF, not all previous research has found 
increased tenderness with increased quality grade (Romans et al., 1965; Miller et al., 1997). 
Warner-Bratzler Shear Force values not differing between S and C steaks is consistent with 
findings of Miller et al. (1997) where WBSF values were 2.39 and 2.29 respectively. This could 
be due to marbling being on a continuous scale, with an arbitrary boundary placed between S and 
C, resulting in marbling scores relatively similar to one another that are in different USDA 
quality grades. Current USDA quality grade standards place a high value on marbling scores to 
determine quality grade, but much inconsistency within quality grade for beef palatability is still 
seen (Miller et al. 1997). 
Many studies have shown increased palatability traits with increased marbling scores 
(Tatum et al., 1982; Wheeler et al., 1994; Guelker et. al., 2013) and is consistent with the results 
from the present study, where C steaks were more desirable than S steaks for initial and 
sustained juiciness, myofibrillar tenderness, overall connective tissue amount, and overall 
tenderness. Increased USDA quality grade is associated with increased palatability traits, which 
was also in agreement with the present study. In contrast, the 2010 National Beef Tenderness 
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Survey found no differences in palatability traits when comparing USDA S and C loin steaks 
(Guelker et al., 2013).  
Warner-Bratzler Shear Force values and SSF values were relatively high for this study 
compared to other studies for these quality grades. The cause of this trend is unknown, but is 
most likely attributed to pre-slaughter effects such as genetic or other factors outside of the scope 
of this project. Warner-Bratzler Shear Force and SSF values were consistent with one another for 
steaks 
 Conclusion 
These data suggest that liver abscesses do not impact meat tenderness, flavor, or other 
sensory attributes. This is beneficial knowledge for the livestock and meat industries given the 
current high prevalence of liver abscesses. In the future, it is possible that some liver abscess 
prevention methods, such as tylosin phosphate may be more heavily regulated. Other liver 
abscess preventions are currently being investigated, but none are widely used in the cattle 
feeding industry. While many of the ramifications of removing tylosin phosphate from finishing 
rations are unknown, it is now known that meat tenderness will not be impacted if prevalence of 
liver abscesses increases.  
Although there were no differences in meat tenderness due to liver abscess score, liver 
abscesses still have a significant impact on margins in the beef industry due to decreased feedlot 
performance and marbling. Research on liver abscess prevention without the aid of 
antimicrobials is still warranted. Further possible extensions of this work include the effect of 
other animal health concerns on meat quality and length of postmortem aging on tenderness 
differences due to liver abscesses.  
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 Tables 1 
Table 2.1 Least squares means and SEM for the effect of liver abscess score on Warner-Bratzler Shear Force, Slice Shear 2 
Force, and cook-loss for USDA Low Choice and Select beef strip loin steaks of finished feedlot steers not fed tylosin phosphate. 3 
 Treatments  
 Quality Grade Liver Abscess Score1 QG×LA 
Item 
Select 
(n = 57) 
Low Choice 
(n = 62) SEM1 P-Value 
None 
(n = 43) 
Mild 
(n = 40) 
Severe 
(n = 36) SEM P-Value P-Value 
WBSF2, kg 4.53 4.22 0.13 0.09 4.42 4.34 4.35 0.17 0.91 0.38 
SSF3, kg 28.48 26.93 0.39 0.39 29.02 26.69 27.41 1.62 0.52 0.61 
Cook Loss, % 15.96 16.03 0.87 0.87 16.42 15.57 16.00 0.37 0.21 0.15 
abMeans within a row with different superscripts differ at the P ≤ 0.05 significance level. 4 
1None- healthy liver, no abscess 5 
Mild- 1 abscess less than 2 cm in diameter to 4 abscesses less than 4 cm in diameter 6 
Severe- 1 abscess greater than 4 cm in diameter or greater than 4 small abscesses 7 
2WBSF = Warner-Bratzler Shear Force  8 
3SSF = Slice Shear Force9 
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Table 2.2 Least squares means and SEM for the effects of liver abscess score on sensory analysis panel items for USDA Low 
choice and Select beef strip loin steaks in finished feedlot steers not fed tylosin phosphate. 
 Treatments  
 Quality Grade Liver Abscess Score2 QG×LA 
Item Select 
(n = 57) 
Low Choice 
(n = 62) SEM1 P-Value 
None 
(n = 43) 
Mild 
(n = 40) 
Severe 
(n = 36) SEM1 P-Value P-Value 
Initial Juiciness3 55.11a 59.06b 1.42 0.01 57.83 56.50 56.93 1.61 0.71 0.37 
Sustained Juiciness 46.20a 49.58b 1.26 0.01 48.18 47.62 47.86 1.45 0.94 0.66 
Myofibrillar 
Tenderness 
57.51a 62.41b 1.53 0.02 59.84 60.84 59.21 1.90 0.81 0.03 
Connective Tissue 
Amount 
17.05a 13.89b 1.38 0.03 15.24 14.84 16.33 1.60 0.70 0.06 
Overall Tenderness 53.96a 58.81b 1.65 0.03 56.62 57.20 55.33 2.05 0.79 0.08 
Beef Flavor Identity 47.05 48.39 0.87 0.27 48.39 47.67 47.10 1.10 0.68 0.10 
Off Flavor 0.91 0.60 0.31 0.38 0.84 0.61 0.81 0.37 0.85 0.65 
ab Means within a row with different superscripts differ at P ≤ 0.05 significance level. 
1None- healthy liver, no abscess; Mild- 1 abscess less than 2 cm in diameter to 4 abscesses less than 4 cm in diameter; Severe- 1 
abscess greater than 4 cm in diameter or greater than 4 small abscesses 
3Sensory Scores: 0 = Extremely dry/tough/non/bland; 100 = Extremely juicy/tender/abundant/intense; 50 = neither dry nor juicy, 
neither tough nor tender. 
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 Figures 
Figure 2.1 Least squares means of the effect of liver abscess score on myofibrillar tenderness by USDA quality grade for beef 
strip loin steaks from finished feedlot steers not fed tylosin phosphate on a continuous 1-100 scale. 
  
a, b, c, d, eMeans with common letters differ at significance level of P ≤ 0.05.  
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Liver Score Descriptors: None = healthy liver, no abscesses ; Mild = 1 abscess less than 2 cm in diameter to 4 abscesses less than 4 cm 
in diameter; Severe = 1 abscess greater than 4 cm in diameter or greater than 4 small abscesses 
Number of Observations: Low choice-none: n=22; Low choice-mild: n=20; Low choice-severe: n=20; Select-none: n=21; Select-mild: 
n=20; Select-severe: n=16 
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Chapter 3 - Subcutaneous Injection Safety Study for Cattle 
Inoculated with VaxLiant® Adjuvants Assembled with Vaccine 
Factions of Fusobacterium necrophorum. 
 Abstract 
The primary objective of this study was to record any adverse reactions in cattle 
following vaccination and revaccination with 3 autogenous Fusobacterium necrophorum vaccine 
formulations with different adjuvants compared to cattle that receive a placebo control.  Bos 
Taurus steers (n=40; approx. 340 kg) were used to test the safety of 3 autogenous F. 
necrophorum vaccines. Each vaccine contained 6 strains Fusobacterium necrophorum sp. 
necrophorum bacterim in combination with an adjuvant. Vaccine A included adjuvant 1 at a 20% 
inclusion rate, vaccine B included adjuvant 2 at a 10% inclusion rate, vaccine C included 
adjuvant 3 at a 15% inclusion rate, and vaccine d contained the antigen and a sterile buffered 
saline. Each vaccine was administered subcutaneously at a 2 cc dose. Cattle were vaccinated on 
day 0 and revaccinated on day 14. Cattle were checked for injection site nodules and rectal 
temperatures were taken on days 1, 2, 14, 15 and 16 of the study. If a nodule was present, 
calipers were used to measure nodule diameter which was also recorded. The PROC GLIMMIX 
procedure of SAS was used to analyze data. All cattle were healthy for the duration of the study. 
There were no differences in rectal temperature for cattle vaccinated with any of the vaccine 
formulas on day 0, 1, or 2 (P > 0.05). There were no differences in rectal temperatures between 
cattle administered any of the vaccine formulations on day 14, 15, or 16 (P > 0.05). Between day 
14 and 15, cattle receiving vaccine A had a greater increase in body temperature than cattle that 
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received vaccine D. Cattle that received vaccine D had fewer observed injection site nodules 
than vaccines A, B, or C. All 3 autogenous vaccine preparations proved to be safe with no 
adverse reactions seen other than small injection site nodules compared to the non-adjuvanted 
placebo vaccine. There were minimal changes or differences in rectal temperature of cattle due 
to vaccine formulation. 
 Introduction 
Vaccination to prevent liver abscesses has been a widely researched area in animal health 
as an alternative to antimicrobial use. Two commercial vaccines have been on the market for 
liver abscess prevention including Fusogard and Centurion. These vaccines have shown to be 
effective in groups of cattle with low prevalences of liver abscesses, but are not effective with 
high prevalence groups (Jones et. al, 2004; Checkley et al., 2005; Fox and Thomson, 2009). As 
the US beef industry strives to reduce antibiotic use, and in turn, decrease the contribution to 
antimicrobial resistance issues, a non-antibiotic liver abscess prevention technique is needed.  
AgriLabs (now Huvapharma) is the parent company of VaxLiant®, who has developed a 
group of adjuvants for use in veterinary biologics production and research.  These adjuvants have 
been shown to be effective in combination with other antigens at increasing immunity to 
pathogens according to research done by AgriLabs. The USDA APHIS CVB approved the first 
of these adjuvants to be used in cattle and swine vaccines. The adjuvant formulas to be tested in 
the present study for cattle were a combination of adjuvants with Fusobacterium necrophorum 
sp. necrophorum for inoculation by subcutaneous administration. These adjuvants have also been 
approved for 21-day slaughter withdrawal in cattle via the subcutaneous and intramuscular route.  
The primary objective of this study was to record any adverse reactions in cattle 
following vaccination and revaccination with 3 autogenous F. necrophorum vaccine 
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formulations with different adjuvants compared to cattle that receive a placebo control.  A 
secondary objective was to observe cattle for changes in rectal temperature or formation of 
injection site lesions due to the different vaccine formulations.  
 Materials and methods 
The Kansas State University Institutional Animal Care and Use Committee approval was 
obtained via protocol number 3976 for this study.  
Cattle:  
Bos Taurus steers (n=40; approximate average weight of 340 kg) were used to test the 
safety of 3 autogenous Fusobacterium necrophorum vaccines. This study was conducted in the 
summer of 2018. Cattle were housed as a group and acclimated to the pen for 21 days before 
study initiation. The pen was a dirt floor lot with a concrete apron and automatic waterers located 
at a private facility in Pottawatomi County Kansas. Cattle were fed once daily and had ad libitum 
access to feed. Cattle were randomly assigned to one of four vaccination test groups: A) 
Fusobacterterium necrophorum antigen (Fn Ag) with adjuvant 1 at 20%; B) Fn Ag with adjuvant 
1 at 10%; C) Fn Ag with adjuvant 2 at 15%; or D) Fn Ag in phosphate buffered saline (no 
adjuvant).  Ten cattle were allotted to each vaccine treatment group. Cattle were vaccinated on 
day 0 and revaccinated on day 14 during the 16 day trial with one vaccine. Rectal temperatures 
were taken on day 0, 1, 2, 14, 15 and 16 using a GLA Model M900H rectal probe thermometer 
(GLA Agricultural Electronics, San Luis Obispo, California). Cattle were monitored daily for 
any adverse reactions, clinical signs of illness or injury.   
Vaccination: 
On day 0, a 3 × 3 in2 area of hair was clipped using a size 10 clipper blade on the left side 
of the neck for the initial vaccination. New disposable 3 mL syringes with 16 gauge, 5/8 in. 
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needles were used for injections on each animal. A 2 cc dose of vaccine treatment assigned to 
each animal was administered subcutaneously. On day 14, the cattle’s hair was clipped similarly 
on the right side of the neck and cattle were revaccinated using the same procedures as those 
used for the initial vaccination. Cattle necks were checked for injection site nodules on day 1, 2, 
14, 15 and 16 of the study and presence was recorded. If a nodule was present, calipers were 
used to measure nodule diameter which was also recorded.  
Statistics: 
The PROC GLIMMIX procedure of SAS (version 9.4; SAS Inst. Inc., Carry, NC) was 
used to analyze data. Comparisons between least square means for treatments utilized the PDIFF 
option of the LSMEANS statement. Nodule palpation size and rectal temperature were measured 
with animal as the experimental unit. Treatment was included in the model as a fixed class effect. 
Statistical significance was determined at P ≤ 0.05. 
Results and discussion 
Adverse reactions: 
All cattle were healthy for the duration of the study. No animals had to be removed from 
the study for any reason. These results indicate that this vaccine does not adversely impact 
animal health during the time immediate following vaccination and revaccination. 
Rectal Temperature: 
There were no differences in rectal temperature for cattle vaccinated with any of the 
vaccine formulas on day 0, 1, or 2 body temperature (P > 0.05; Figure 3.1). There were also no 
differences between cattle due to vaccination group for the change in rectal temperature from 
baseline (day 0) to day 1 or 2 (P > 0.05; Table 3.4). Mean rectal temperature for all cattle 
50 
 
regardless of vaccination group increased numerically between day 0 and 1, and decreased 
between day 1 and 2.  
The rectal temperatures of the test cattle taken day 0, 1 and 2 were abnormally elevated 
over expected rectal temperatures of healthy cattle. High ambient temperatures and temperature 
humidity index (Figure 3.3) on the days prior to and through this recording period attributed to 
the elevated rectal temperatures in the test cattle. Nighttime temperatures in the days leading up 
to the initiation of the trial were elevated and cattle were unable to offload heat. Maximum 
ambient temperatures for the day before trial initiation was 97o F with 76% humidity and 
remained high for both temperature and humidity for d 1 and 2 of the study. This resulted in 
elevated body temperatures in the morning, being exacerbated by the increasing temperatures 
throughout the day. Temperature humidity index has been positively correlated to rectal 
temperature, with rectal temperature being indicative of core body temperature (Alhidary, et al., 
2012; Bernardini, et al., 2012; Kaufman, et. al., 2018).  
There were no differences in rectal temperatures between cattle administered any of the 
vaccine formulations on day 14, 15, or 16 (P > 0.05; Figure 3.2). Between day 14 and 15, cattle 
receiving vaccine A had a greater increase in body temperature than cattle that received vaccine 
D (1.17 vs -0.24 o F; P < 0.05). There were no differences in rectal temperature among cattle 
receiving any of the vaccine formulations for differences in rectal temperature differences 
between days 15 and 16 or days 14 and 16.  
Rectal temperatures of test cattle were closer to expected normal range of healthy during 
revaccination and the following observations. The ambient temperatures and THI were lower 
during this time period.  
Injection Site Observations: 
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Table 3.2 contains categorical injection site observation data. Cattle that received vaccine 
D had fewer observed injection site nodules than vaccines A, B, or C. Cattle receiving vaccine A 
or B had larger injection site nodules on day 1 than cattle receiving vaccine formulation D (P < 
0.05; Table 3.3). There were no differences in diameter of injection site nodules for cattle 
receiving vaccine A, B or C on day 2, 15 or 16 of the study. Cattle vaccinated with the placebo 
(no adjuvant) formulation had smaller diameter injection site nodules on day 1, 2, 15 and 16 of 
the study.  Anecdotally, many injectable products used in the beef industry, both vaccines and 
antibiotics will temporarily leave injection site nodules with any complications arising from 
them.  
Two steers still had a palpable nodule on day 14 following the initial vaccination (one 
steer receiving vaccine A (1.0 cm nodule) and a steer receiving vaccine C (2.3 cm nodule)).  
Feed Intake Observations: 
Since all cattle were housed together, feed intake between treatments cannot be 
compared. Due to cattle temperament, it was difficult to monitor group appetite following 
vaccination. Daily total feed offerings to the pen are in Figure 4.4. Cattle were fed a grower diet 
consisting of silage and corn gluten feed. The day of the initial vaccination, the cattle did not 
clean the bunk, so day 1 of the study, cattle were cut back from 681.8 to 454.5 kg. Day 2, cattle 
did not clean the bunk, so they were fed 454.5 kg again. For the remainder of the study, cattle 
cleaned the bunk daily including the day of revaccination and days 15 and 16. The initial drop in 
feed intake was most likely due to THI and processing stress combined and not related to the 
vaccines themselves. During the revaccination time, cattle cleaned the bunk daily. Cattle were 
fed step-up increments consistent with the grow yard protocols throughout the study duration.  
52 
 
 Conclusions 
All 3 autogenous vaccine preparations proved to be safe with no adverse reactions seen 
other than small injection site nodules compared to the non-adjuvanted placebo vaccine. No 
animals had to be removed from the trial for any adverse reactions. There were minimal changes 
or differences in rectal temperature of cattle due to vaccine formulation. Vaccines with the 
adjuvant included in the formulation had increased presence of injection site nodules the next 
day or two post-vaccination compared to cattle vaccinated with the non-adjuvant control vaccine. 
These vaccine injection site nodules resolved to nearly undetectable levels by two weeks after 
the initial vaccine. Cattle vaccinated with vaccine A or B had larger diameter nodules on their 
neck on day 1 post-vaccination compared to cattle receiving vaccine D, the placebo. However on 
day 2 and later, cattle vaccinated with vaccine A, B or C had larger diameter nodules on the neck 
than cattle that received vaccine D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
53 
 
 Literature Cited 
Alhidary, I. A., S. Shini, R. A. M. Al Jassim, and J. B. Gaughan. 2012. Physiological responses 
of Australian Merino wethers exposed to high heat load. J. Anim. Sci. 90:212-220.  
Bernardini, D., G. Gerardi, A. Peli, L. Nanni Costa, M. Amadori, and S. Segato. 2016. The 
effects of different environmental conditions on thermoregulation and clinical and 
hematological variables in long-distance road-transported calves. J. Anim. Sci. 90:1183-
1191. 
Checkley, S. L., E. D. Janzen, J. R. Campbell, J. J. McKinnon. 2005. Efficacy of vaccination 
against Fusobacterium necrophorum infection for control of liver abscesses and footrot 
in feedlot cattle in western Canada. Can. Vet. J.. 46:1002-1007. 
Fox, J. T., D. U. Thomson, N. N. Lindberg, K. Barling. 2009. A comparison of two vaccines to 
reduce liver abscesses in natural-fed beef cattle. Bovine Practitioner. 43: 168-174.  
Jones, G., H. Jayappa, B. Hunsaker, D. Sweeney, V. Rapp-Gabrielson, T. Wasmoen, T. G. 
Nagaraja, S. Swingle, M. Branine.2004. Efficacy of an Arcanobacterium pyogenes-
Fusobacterium necrophorum bacterin-toxoid as an aid in the prevention of liver 
abscesses in feedlot cattle. Bov. Pract. 38:36-44.  
Kaufman, J. D., A. M. Saxton, and A. G. Rius. 2018. Short communication: Relationships 
among temperature-humidity index with rectal, udder surface, and vaginal temperatures 
in lactating dairy cows experiencing heat stress. J. Dairy Sci. 101:6424-6429.  
 
 
 
54 
 
 Tables 
Table 3.1 VaxLiant® Adjuvants combinations assembled with vaccine factions of 
Fusobacterium necrophorum composing the four treatment groups.  
TREATMENT 
GROUP 
PRODUCT1 
NUMBER OF 
CATTLE 
A Fn Ag (IVP)/Adjuvant 1 20% 10 
B Fn Ag (IVP)/Adjuvant 1 10% 10 
C Fn Ag (IVP)/Adjuvant 2 15% 10 
D FN AG (MPC) PB SALINE 10 
 
1All product was administered subcutaneously.  
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Table 3.2 Number of injection site reactions following initial vaccination with vaccines 
containing VaxLiant® Adjuvants assembled with factions of Fusobacterium necrophorum. 
 
VACCINATION GROUP 
Day 1 Day 2 
A 
(n=10) 
B 
(n=10) 
C 
(n=10) 
D 
(n=10) 
A 
(n=10) 
B 
(n=10) 
C 
(n=10) 
D 
(n=10) 
NODULE 7 7 5 2 9 9 7 1 
MILD EDEMA 0 2 2 1 1 1 3 0 
NO NODULE 3 1 3 7 0 0 0 9 
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Table 3.3 Number of injection site reactions following revaccination with vaccines containing 
VaxLiant® Adjuvants assembled with factions of Fusobacterium necrophorum. 
 
REVACCINATION GROUP 
Day 15 Day 16 
A 
(n=10) 
B 
(n=10) 
C 
(n=10) 
D 
(n=10) 
A 
(n=10) 
B 
(n=10) 
C 
(n=10) 
D 
(n=10) 
NODULE 10 8 9 3 10 9 10 2 
MILD EDEMA 0 2 1 2 0 1 0 1 
NO NODULE 0 0 0 5 0 0 0 7 
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Table 3.4 Least squared means for injection site nodule size by vaccine treatment group following 
vaccination with vaccines containing VaxLiant® Adjuvants assembled with factions of 
Fusobacterium necrophorum. 
 
 
 
abMeans within a row with different superscripts differ at P ≤ 0.05 significance level. 
1Standard Error of the Mean 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VACCINATION GROUP  
A B C D SEM1 P-Value 
NODULE SIZE (CM) D1 1.89a 2.00a 1.25ab 0.34b 0.392 0.02 
 
D2 2.50a 2.94a 2.05a 0.17b 0.341 <0.01 
D15 3.21a 2.20a 2.55a 0.41b 0.295 <0.01 
D16 3.79a 3.26a 3.56a 0.36b 0.322 <0.01 
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Table 3.5 Least squared means for temperature differences (oF) between vaccine administration 
and 24 to 48 hours after vaccination with vaccines containing VaxLiant® Adjuvants assembled 
with factions of Fusobacterium necrophorum. 
 
VACCINATION GROUP  
A B C D SEM1 P -Value 
DIFFERENCE IN 
STUDY DAYS2 
0-1 0.30 0.40 0.26 0.71 0.354 0.80 
 
0-2 -0.94 -1.09 -1.80 -0.88 0.336 0.23 
1-2 -1.24 -1.49 -2.06 -1.59 0.338 0.33 
14-15 1.17a 0.78ab 0.23ab -0.24b 0.315 0.02 
14-16 0.56 0.65 0.29 -0.08 0.291 0.30 
15-16 -0.61 -0.13 0.06 0.16 0.364 0.46 
 
ab Means within a row with different superscripts differ at P ≤ 0.05 significance level. 
1Standard Error of the Mean 
2This is the initial temperature subtracted from the later day’s temperature (ex: 0-1 is average 
temperature for day 0 subtracted from average temperature from day 1). 
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 Figures 
Figure 3.1 Rectal temperature at vaccination, and day 1 and 2 following vaccination with vaccines 
containing VaxLiant® Adjuvants assembled with factions of Fusobacterium necrophorum. 
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Figure 3.2 Rectal temperature at revaccination, and day 1 and 2 following revaccination with 
vaccines containing VaxLiant® Adjuvants assembled with factions of Fusobacterium 
necrophorum. 
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Figure 3.3 Maximum and average Temperature Humidity Index (THI) prior to and throughout 
the duration of the study investigating vaccines containing VaxLiant® Adjuvants assembled 
with factions of Fusobacterium necrophorum. 
 
aVaccination data collection period has a blue box surrounding it and revaccination data collection 
periods has a green dotted box. 
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Figure 3.4 Feed offered to the pen daily throughout the duration of the study investigating 
vaccines containing VaxLiant® Adjuvants assembled with factions of Fusobacterium 
necrophorum. 
 
aVaccination data collection period is in the blue dotted box and revaccination data collection period is in 
the green dotted box.  
bData was not collected between Sept. 16th and 23rd. Through Sept. 16th cattle were cleaning up 1400 lbs 
daily, and they were bumped up to 1500 lbs daily by Sept. 23rd.  
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Figure 3.5 Injection site nodule (3.0 cm) on the day after vaccination (d 1) in steer 
administered vaccine B containing a VaxLiant® Adjuvant assembled with factions of 
Fusobacterium necrophorum. 
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Figure 3.6 Injection site nodule (2.5 cm) on the day after vaccination (d 1) in steer 
administered vaccine A containing VaxLiant® Adjuvant assembled with factions of 
Fusobacterium necrophorum. 
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Figure 3.7 Injection site nodule (3.1 cm) the day after revaccination (d 15) in steer administered 
vaccine C, containing VaxLiant® Adjuvant assembled with factions of Fusobacterium 
necrophorum. 
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Figure 3.8 Injection site nodule (5.0) two days after revaccination (d 16) in steer administered 
vaccine A, containing VaxLiant® Adjuvant assembled with factions of Fusobacterium 
necrophorum. 
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Figure 3.9 Injection site nodule (4.6 cm) two days following revaccination (d 16) in steer 
administered vaccine C, containing VaxLiant® Adjuvant assembled with factions of 
Fusobacterium necrophorum. 
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Figure 3.10 Same steer as Image 3.9 two days after revaccination (d 16) VaxLiant® 
Adjuvant assembled with factions of Fusobacterium necrophorum without calipers 
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Chapter 4 - The effects of an autogenous vaccine containing an 
adjuvant assembled as a Fusobacterium necrophorum multivalent 
autogenous vaccine on health, production and carcass 
characteristics including liver abscess incidence in feeder cattle 
 Abstract 
Vaccination against the causative agent of liver abscesses, Fusobacterium necrophorum 
(F. necrophorum) shows potential to reduce liver abscesses in feeder cattle. This study was a 
production trial investigating the efficacy of the autogenous vaccine against F. necrophorum at 
reducing liver abscesses in feeder cattle, and the effects of the vaccine on animal health, gain, 
and carcass data. Natural-fed cattle (n=996 hd; 848 ± 72 lbs) were enrolled upon feedlot 
processing and randomly assigned to treatment groups of vaccinates or controls. Vaccinates were 
administered a 2cc dose of the autogenous F. necrophorum vaccine and were revaccinated 14-28 
days later. Control and vaccinated cattle were commingled within pens in a 1:1 fashion and no 
further interventions were implemented during the finishing period. All cattle were fed as part of 
a natural program, therefore Tylosin was not included in the diet. At slaughter, carcass data and 
liver abscess scores were collected using the Elanco Liver Check scoring system. Liver abscess 
prevalence did not differ between controls and vaccinates (37.4 vs 34.1%; P = 0.10), nor did 
prevalence of severe liver abscesses (15.4 vs 13.7%; P = 0.15). There were no differences 
between control and vaccinated cattle for yield grade, quality grade, enrollment weights, HCW, 
estimated slaughter weight, average daily gain or days on feed (P > 0.14). Results indicate this 
vaccine does not reduce liver abscess prevalence in feedlot cattle and does not have an impact on 
carcass parameters. 
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 Introduction 
Liver abscesses are a common issue in the United States cattle feeding industry, with the 
most recent National Beef Quality Audit recording 17.8% of the fed cattle observed at abattoirs 
to have had liver abscesses (Eastwood, et al., 2017). The most common bacterial pathogen 
isolated in liver abscesses in cattle is Fusobacterium necrophorum, sp. necrophorum (F. 
necrophorum), which has been isolated from up to 100% of liver abscesses seen at the time of 
slaughter (Nagaraja and Chengappa, 1998; Nagaraja et al., 1999). Vaccination against this 
causative agent has previously shown potential to reduce liver abscesses in feeder cattle. 
Previous vaccines have been found to be effective in groups of cattle with relatively low 
prevalence of liver abscesses (Checkley, 2005; Jones, 2004). This study investigated a vaccine 
against F. necrophorum sp. necrophorum that contained an adjuvant from Huvepharma 
(previously AgriLabs VaxLiant®) that was developed for use in veterinary biologics. Previous 
company research has demonstrated favorable results in improved immune response and a 
superior safety profile utilizing various antigens in combination with this adjuvant. This product 
has documented adjuvant licensure safety and a 21 day slaughter withdrawal. This vaccine was 
previously proven safe for use in cattle, not resulting in any observed adverse effects in a 40 head 
safety study. 
This study was a large scale production trial investigating 1) the efficacy of the 
autogenous vaccine against F. necrophorum at reducing liver abscesses in feeder cattle, and 2) 
the effects of the autogenous vaccine against F. necrophorum on animal health, feedlot and 
carcass data. Feeder cattle were enrolled in the study between April and June of 2018 at 2 
cooperating feedyards near Scott City, Kansas. A total of 3,591 hd were enrolled in the study, 
947 hd split between 7 lots of cattle at Feedyard A and 2,644 hd split between 23 lots at 
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Feedyard B. Cattle were harvested between September of 2018 and March of 2019 at 
commercial abattoirs in Southwest Kansas and Nebraska.  
 Materials and methods 
The Kansas State University Institutional Animal Care and Use Committee approval was 
obtained via protocol number 4085 for this study.  
Enrollment:   
Lots of natural cattle were selected at feedlot arrival to participate in the study. Within 
pen, cattle were randomly allotted to treatment, so that each pen was comprised of half 
vaccinated cattle and half control cattle. Treatments consisted of control cattle that did not 
receive the F. necrophorum autogenous vaccine and vaccinated cattle that received a 2cc 
injection subcutaneously at the time of processing upon arrival, and a revaccination 14-28 days 
after the initial vaccination. Vaccines were transported, stored and administered according to 
manufacturer instructions.  All cattle received the processing vaccines typical for the feedyard in 
addition to the study treatment allocated to them and all cattle, including controls were brought 
through the working facility upon vaccination and revaccination. The randomization procedures 
and vaccinations were observed by trained personnel under the supervision of the feedlot’s 
veterinary consultant. After processing, cattle were put into their home pen for routine health and 
behavior observations and no further interventions were implemented other than what was 
routine for the feedlot. Cattle were fed as part of a natural program, therefore diets did not 
contain tylosin. Finishing ration formulations can be found in Table 5 for Feedyard A and Table 
6 for Feedyard B. All cattle received an electronic individual animal identification (EID) and the 
treatment they received in the processing barn was recorded with the EID for future tracking of 
the cattle health and performance using the animal health computer system at the feedlot.  
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Animal health data was gathered retrospectively from the animal health computer after lot 
closeout.  
Carcass Data:   
At slaughter, a carcass data collection team from the West Texas A&M University Beef 
Carcass Research Center collected individual carcass data including liver abscess scores visually, 
and hot carcass weight (HCW), yield grade and quality grade from the abattoirs’ grading system. 
Livers were scored according to the Elanco Liver Check System with the following categories: 0 
= free of abscesses, parasites, or other pathological abnormalities; A- = ≤ 2 abscess ≤ 2 cm in 
diameter or resolved abscess scars; A = 2 to 4 abscesses 2 to 4 cm in diameter; A+ = ≥ 1 
abscesses > 4 cm in diameter or > 4 abscesses > 2 cm in diameter; and A+Adhesions = 
Abscesses adhered to the diaphragm, other organs, or the abdominal cavity. If livers were 
condemned for any reason, no liver score was obtained. Estimated slaughter weight was 
calculated using hot carcass weight and an average dressing percentage of 63%.  
 Due to a communication failure, 5 lots of (Feedyard B) cattle were shipped 
without notifying researchers, so liver abscess data was not collected on these 738 cattle. Yield 
grade, quality grade and HCW was obtained from the packer for 4 of these lots.  
Data Analysis:    
This study implemented a randomized complete block design with feedlot and pen being 
the blocking factors. Individual animal was the experimental unit. Study endpoints were 
analyzed using either the generalized linear mixed model or the linear mixed model.  Fixed 
effects of the model included feedlot (A, B) and treatment (VAC, CON). Bodyweight at 
enrollment served as the covariate. Pen nested within feedlot was the random effect of the model. 
Binary endpoints, including incidence for liver abscess (Normal, A- vs. A, A+, A+Adh), severe 
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liver abscess (Normal, A-, A vs. A+ A+Adh), morbidity and mortality, were analyzed under the 
generalized linear mixed model with logit link.  Ordinal endpoints, including liver abscess 
scores, USDA quality grade and yield grade, were analyzed under the generalized linear mixed 
model with cumulative logit link. HCW and ADG are continuous endpoints.  These two 
endpoints were analyzed under the linear mixed model with identity link.  For binary and ordinal 
endpoints, rates of incidences and the standard errors were reported for each treatment.  
Treatment effect was evaluated via the 2-sided test for non-one (cumulative) odds ratio.  For 
continuous endpoints, least square (LS) means and their standard errors were reported for each 
treatment. Treatment effect was evaluated via the 2-sided test for non-zero mean difference.  
Statistical analysis was performed using the SAS (Version 9.4; SAS Inst. Inc., Cary, NC) PROC 
GLIMMIX. 
 Results 
Liver abscess data:   
Liver abscess data were obtained and analyzed for 2,344 hd and can be found in table 4.2 
and figure 4.1. Table 4.2 summarizes liver data by lot in counts and prevalence. Figure 4.1 
displays the prevalence of liver abscess categories by treatment group. Overall prevalence of 
liver abscesses by lot ranged from 4.4 to 80.3%. Liver abscess prevalence did not differ between 
controls and vaccinates (37.4 vs 34.1%; P = 0.10), nor did prevalence of severe liver abscesses 
(15.4 vs 13.7%; P = 0.15). 
Carcass Data:  
 Carcass data was obtained for 2,992 head and can be found in Figures 4.2 and 4.3.  Yield 
grade did not differ between control and vaccinated cattle (P = 0.35) nor did the quality grade (P 
= 0.46). HCW did not differ between control and vaccinated cattle (777.4 vs 774.7 lb; P = 0.14). 
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Performance and Health Data:   
Table 4.3 summarizes performance and health data by treatment. There were no 
differences between control and vaccinated cattle for enrollment weights (749 vs 746 lb; P = 
0.52), nor for HCW (777.4 vs 774.7 lb; P = 0.14). Average daily gain did not differ between 
control and vaccinated cattle (2.97 vs 2.94 lb; P = 0.15). There was no difference between 
controls and vaccinates for morbidity (7.3 vs 8.5%; P = 0.20) or mortality (2.1 vs 1.5%; P = 
0.23).   
 Discussion 
This research agrees with Fox and Thomson (2009) who tested 2 other vaccines 
(Fusogard and Centurion) against liver abscesses in beef cattle caused by F. necrophorum. They 
found that neither of these vaccines reduced liver abscess prevalence or severity in a group of 
cattle that had high liver abscesses prevalence (56% total abscess prevalence, 39% severe). 
Additionally in agreement with this research, Fox and Thomson found that these neither 
Fusogard nor Centurion affected hot carcass weight, yield grade, or quality grade.  
Previously, vaccines have been found to decrease prevalence and severity of liver 
abscesses in groups of cattle with low prevalence of liver abscesses at the time of slaughter 
(Checkley, et al., 2005; Jones et al., 2004). A T. pyogenes - F. necrophorum bivalent bacterin-
toxoid vaccine, Centurion (Originally Schering-Plough Corp, now Merck Animal Health; 
Omaha, NE) was found in two studies to reduce liver abscess prevalence by 37.5 to 48.4% (16% 
vaccines vs 31% controls in study one and 30% vaccinates vs 48% controls in study two) in 
cattle on a high grain ration. The vaccine contained an inactivated F. necrophorum leukotoxin 
and T. pyogenes pyolysin that was used in combination with a water-in-oil adjuvant, however 
this product is no longer available commercially.   
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Fusogard (Elanco Animal Health US, Inc, Greenfield, IN) is a currently available F. 
necrophorum bacterin vaccine. This vaccine has been shown to be effective in groups of cattle 
with low overall prevalence of liver abscesses (decreasing overall abscesses from 10% to 2%), 
but is less effective in groups of cattle with an increased overall prevalence (decreasing abscesses 
from 30% to 24%; Checkley, et al., 2005) or not effective at all as found by Fox and Thomson 
(2009) in cattle with a 59% abscess prevalence.  
The vaccine researched in this article is the first autogenous liver abscess prevention 
vaccine to be investigated. Historically for other conditions, autogenous vaccines have little 
efficacy data available. O’Conner et al. (2011) found that an autogenous vaccine against 
Moraxella bovis was not effective at controlling naturally-occurring Infectious Bovine 
Keratoconjunctivitis (pinkeye) in calves. While these disease processes are very different, this 
demonstrates that although little research is published on the efficacy of autogenous vaccines, the 
research that is available widely does not support their use. 
 The vaccine being researched here is an autogenous bacterin vaccine, meaning that the 
vaccine contained killed bacteria collected from the geographical area where the vaccine was 
used. The bacteria was collected at the time of slaughter from lots of cattle that had mild to 
severe liver abscesses. It is possible that the strains of F. necrophorum used in this vaccine did 
not match those strains affecting the majority of cattle on trial. Little is known about strain 
variation of F. necrophorum regionally and exactly how this affects liver abscess prevalence and 
severity of feedlot cattle but it is speculated that the soil microbiome differences contributes to 
the regional variation in liver abscess prevalence (Weinroth, et al., 2019). Cattle likely arrive at 
the feedlot with F. necrophorum strains in their rumen from their ranch or backgrounding 
operation of origin, which may differ from the strains collected and used in the vaccine. 
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Many vaccines contain components that target specific virulence factors of bacteria as 
opposed to a bacterin vaccine like this one that contains entire killed bacteria cells. With some 
bacteria this can lead to an increased efficacy at encouraging the body to mount an adequate 
immune response against virulent bacteria and may help explain the low efficacy of the vaccine 
in question. Although this vaccine was previously proven safe and no adverse reactions were 
seen in this large scale study, it is notable that component vaccines are also known for creating 
fewer adverse reactions than killed bacterin vaccines (Richeson et al, 2019). Endotoxins are in 
the cell wall of gram-negative bacteria and could be responsible for causing an anaphylactic 
shock reaction in a killed bacterin vaccine (Richeson et al., 2019).  
To summarize these findings, currently there are no vaccines on the market that are 
effective at reducing liver abscess prevalence or severity in groups of cattle with high 
prevalence, including the autogenous vaccine researched in this article. More research is needed 
to find a vaccine that is capable of preventing liver abscesses. Targeting specific virulence factor 
genes appears to be a more effective approach at liver abscess prevention than killed bacterin 
vaccines.  
 Conclusions 
Results from this experiment indicate that use of this autogenous vaccine against F. 
necrophorum did not impact liver abscess prevalence or severity, animal health, feedyard or 
carcass performance in cattle that had an average feedlot entry weight of 758 lbs. Further 
research is needed to find a vaccine that is capable of preventing liver abscesses in groups of 
cattle with high prevalence of liver abscesses.  
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 Tables 
Table 4.1 Descriptive data of all lots for which data was obtained when investigating an 
autogenous vaccine containing an adjuvant assembled as a Fusobacterium necrophorum 
multivalent autogenous vaccine. 
Feedlot Lot 
Head in Pen at 
Slaughter 
Average In 
Weight (lbs) 
Average HCW 
(lbs)  Sex 
A N455 84 844 ± 78 779 ± 72 Steers  
A N457 52 916 ± 76 770 ± 55 Heifers 
A N458 123 832 ± 87 739 ± 74 Steers 
A N459 131 824 ± 77 743 ± 70 Steers 
A N460 165 839 ± 56 797 ± 63 Steers 
A N461 174 828 ± 73 776 ± 74 Heifers 
A N462 166 841 ± 65 783 ± 66 Steers 
B 7890 188 752 ± 64 814 ± 61 Heifers 
B 7893 58 650 ± 52 834 ± 71 Heifers 
B 7896 113 758 ± 69 769 ± 68 Heifers 
B 7901 248 750 ± 66 841 ± 65 Heifers 
B 7902 67 702 ± 42 827 ± 64 Heifers 
B 7903 59 723 ± 55 859 ± 67 Heifers 
B 7906 56 777 ± 85 852 ± 85 Mixed 
B 7915 55 764 ± 65 846 ± 63 Heifers 
B  7920 101 860 ± 65 836 ± 64 Steers 
B 7921 206 782 ± 68 851 ± 70 Heifers 
B 7933 67 713 ± 68 790 ± 75 Mixed 
B 7934 30 847 ± 57 884 ± 70 Steers 
B 7936 58 811 ± 101 900 ± 72 Steers 
B 7941 38 474 ± 74 764 ± 67 Heifers 
B 7942 37 516 ± 70 806 ± 66 Steers 
B 7943 212 902 ± 67 903 ± 86 Heifers 
B 7944 81 514 ± 50 786 ± 91 Mixed 
B 7950 178 515 ± 50 728 ± 68 Mixed 
B 7951 96 429 ± 51 723 ± 67 Mixed 
B 7952 89 669 ± 86 779 ± 78 Heifers 
B 7953 175 719 ± 71 797 ± 72 Heifers 
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Table 4.2 Overall counts and prevalence of liver abscesses by lot for the efficacy study of an autogenous vaccine containing an 
adjuvant assembled as a Fusobacterium necrophorum multivalent autogenous vaccine. 
Lot  Counts Prevalence, % 
  . 0 1 2 3 4 All . 0 1 2 3 4 
458 
CON 1 38 7 3 5 9 63 1.6 60.3 11.1 4.8 7.9 14.3 
VAC 1 41 3 7 2 7 61 1.6 67.2 4.9 11.5 3.3 11.5 
N455 
CON 5 28 5 . 1 2 41 12.2 68.3 12.2 . 2.4 4.9 
VAC . 38 3 . 2 2 45 . 84.4 6.7 . 4.4 4.4 
N457 
CON 2 19 3 1 . 1 26 7.7 73.1 11.5 3.8 . 3.8 
VAC . 23 . 1 2 . 26 . 88.5 . 3.8 7.7 . 
N459 
CON 3 41 7 6 6 2 65 4.6 63.1 10.8 9.2 9.2 3.1 
VAC . 46 7 3 6 4 66 . 69.7 10.6 4.5 9.1 6.1 
N460 
CON 9 13 29 14 13 5 83 10.8 15.7 34.9 16.9 15.7 6.0 
VAC 6 14 32 22 10 5 89 6.7 15.7 36.0 24.7 11.2 5.6 
N461 
CON 14 18 32 21 10 3 98 14.3 18.4 32.7 21.4 10.2 3.1 
VAC 13 17 26 14 17 7 94 13.8 18.1 27.7 14.9 18.1 7.4 
N462 
CON 14 50 5 3 3 9 84 16.7 59.5 6.0 3.6 3.6 10.7 
VAC 8 60 8 4 3 3 86 9.3 69.8 9.3 4.7 3.5 3.5 
7893 
CON 10 17 1 1 5 2 36 27.8 47.2 2.8 2.8 13.9 5.6 
VAC 6 19 2 3 2 3 35 17.1 54.3 5.7 8.6 5.7 8.6 
7901 
CON 32 101 7 3 5 1 149 21.5 67.8 4.7 2.0 3.4 0.7 
VAC 21 106 1 4 6 3 141 14.9 75.2 0.7 2.8 4.3 2.1 
7902 
CON 2 24 3 2 3 . 34 5.9 70.6 8.8 5.9 8.8 . 
VAC 2 25 3 2 2 . 34 5.9 73.5 8.8 5.9 5.9 . 
7903 
CON 14 18 2 1 . . 35 40.0 51.4 5.7 2.9 . . 
VAC 11 23 . . . . 34 32.4 67.6 . . . . 
7915 
CON 6 18 1 2 2 2 31 19.4 58.1 3.2 6.5 6.5 6.5 
VAC 1 17 2 6 3 2 31 3.2 54.8 6.5 19.4 9.7 6.5 
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7920 
CON 10 24 6 8 7 1 56 17.9 42.9 10.7 14.3 12.5 1.8 
VAC 9 23 8 4 10 1 55 16.4 41.8 14.5 7.3 18.2 1.8 
7933 
CON 3 25 2 2 2 . 34 8.8 73.5 5.9 5.9 5.9 . 
VAC 7 22 2 . 3 1 35 20.0 62.9 5.7 . 8.6 2.9 
7934 
CON 19 11 . . . 1 31 61.3 35.5 . . . 3.2 
VAC 17 10 1 1 1 1 31 54.8 32.3 3.2 3.2 3.2 3.2 
7936 
CON 2 20 4 1 1 2 30 6.7 66.7 13.3 3.3 3.3 6.7 
VAC 7 12 6 1 1 3 30 23.3 40.0 20.0 3.3 3.3 10.0 
7941 
CON 7 12 2 1 2 2 26 26.9 46.2 7.7 3.8 7.7 7.7 
VAC 8 12 1 1 2 1 25 32.0 48.0 4.0 4.0 8.0 4.0 
7942 
CON 7 14 . 2 1 2 26 26.9 53.8 . 7.7 3.8 7.7 
VAC 5 15 . . 2 . 22 22.7 68.2 . . 9.1 . 
7943 
CON 8 40 19 12 33 2 114 7.0 35.1 16.7 10.5 28.9 1.8 
VAC 30 39 8 9 31 5 122 24.6 32.0 6.6 7.4 25.4 4.1 
7944 
CON 3 32 . 1 1 4 41 7.3 78.0 . 2.4 2.4 9.8 
VAC 8 29 5 . 1 . 43 18.6 67.4 11.6 . 2.3 . 
7950 
CON 12 54 8 5 11 7 97 12.4 55.7 8.2 5.2 11.3 7.2 
VAC 19 64 6 4 3 4 100 19.0 64.0 6.0 4.0 3.0 4.0 
7951 
CON 10 31 1 1 7 6 56 17.9 55.4 1.8 1.8 12.5 10.7 
VAC 17 33 2 1 4 1 58 29.3 56.9 3.4 1.7 6.9 1.7 
7952 
CON 15 31 . 4 6 3 59 25.4 52.5 . 6.8 10.2 5.1 
VAC 20 30 4 2 2 2 60 33.3 50.0 6.7 3.3 3.3 3.3 
7953 
CON 27 35 1 4 15 12 94 28.7 37.2 1.1 4.3 16.0 12.8 
VAC 29 37 5 1 9 11 92 31.5 40.2 5.4 1.1 9.8 12.0 
All 
CON 541 714 145 98 139 78 1715 31.5 41.6 8.5 5.7 8.1 4.5 
VAC 532 755 135 90 124 66 1702 31.3 44.4 7.9 5.3 7.3 3.9 
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Table 4.3 Least squares means and SEM for performance and health data following 
vaccination with an autogenous vaccine containing an adjuvant assembled as a 
Fusobacterium necrophorum multivalent autogenous vaccine. 
 Control Vaccinates  SEM P-value 
Enrollment Weight, lbs  749 746 3.5 0.52 
 HCW, lbs  777.4 774.7 11.8 0.14 
ADG, lbs 2.97 2.94 0.05 0.15 
Morbidity, % 7.3 8.5 1.3 0.20 
Mortality, % 2.1 1.5 0.5 0.23 
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Table 4.4 Finishing ration formulation for Feedyard A used in the efficacy study 
investigating an autogenous vaccine containing an adjuvant assembled as a Fusobacterium 
necrophorum multivalent autogenous vaccine. 
Ingredient  % of ration 
Flaked Corn  69.0 
Corn Oil 1.9 
Corn Silage  18.1 
Finisher 6 
Micro-ingredients 1 
STEEP 4 
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Table 4.5 Finishing ration formulation for Feedyard B used in the efficacy study 
investigating an autogenous vaccine containing an adjuvant assembled as a Fusobacterium 
necrophorum multivalent autogenous vaccine. 
Ingredient % of ration 
Triticale Silage 4.4 
Chopped Alfalfa Hay 3.1 
Sunflower Screenings  4.4 
Flaked Corn 66.3 
CS/Cane Molasses (50% cane 
molasses, 50% low sulfur corn 
steep)  
3.3 
Dry Distillers Grain 12.1 
Corn oil 1.8 
Micro-ingredients 1.0 
Finish Protein 3.6 
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 Figures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liver abscess score did not differ by treatment (P = 0.10).  
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Figure 4.1 Liver abscess score by treatment group following vaccination with an 
autogenous vaccine containing an adjuvant assembled as a Fusobacterium 
necrophorum multivalent autogenous vaccine. 
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Figure 4.2 Quality grade data by treatment group following vaccination with an 
autogenous vaccine containing an adjuvant assembled as a Fusobacterium 
necrophorum multivalent autogenous vaccine. 
 
Quality grade did not differ between treatment groups (P = 0.46). 
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Yield grade did not differ between treatment groups (P = 0.35).
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Figure 4.3 Yield grade data by treatment group following vaccination with 
an autogenous vaccine containing an adjuvant assembled as a Fusobacterium 
necrophorum multivalent autogenous vaccine. 
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Chapter 5 - Research Implications 
Liver abscesses are truly a problem found at the junction of animal health, nutrition, and 
husbandry. Moving forward, this is a critical problem for the United States cattle feeding 
industry to address. Results of the project outlined in chapter 2 of this dissertation imply that 
although liver abscesses can negatively impact quality grade, hot carcass weight, and feedlot 
performance, they do not cause decreased meat tenderness or eating quality within quality grade. 
This is good news for the beef industry as we have already seen an increase in the percent of 
carcasses with liver abscesses identified at the time of slaughter. This is partially due to the 
increasing consumer trend of desiring “natural” beef from those animals that have not been 
administered an antibiotic, in addition to the increased regulation surrounding antimicrobial use, 
particularly those deemed critically-important to human medicine like tylosin.  
The autogenous vaccine against F. necrophorum sp. necrophorum researched here in 
chapters 3 and 4 was found to be safe to administer, however does not appear to reduce liver 
abscess prevalence in natural-fed cattle and therefore is not a beneficial product to use in this 
class of cattle. It has been speculated that the regional differences in liver abscess prevalence is 
attributable to differences in the strains of F. necrophorum present in the soil. If this does truly 
contribute to the regional differences, this needs to be taken into account and include strains of F. 
necrophorum that cause abscesses in the area where the vaccine is being used. Vaccine research 
should continue as a possible liver abscess prevention tool. Vaccines can be used in cattle 
enrolled in “natural” programs, which anecdotally have higher liver abscess prevalence than 
conventionally-fed cattle. If vaccines were competitively priced and as efficacious as tylosin, it 
would most likely be used in much of the fed cattle industry. This would be advantageous from a 
ration handling standpoint in that it would remove a daily feed additive (tylosin). Previous 
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vaccines have been found to be effective at decreasing prevalence and severity in groups of cattle 
with low prevalence of liver abscesses. As we continue to learn more about liver abscess 
formation, bacterial virulence factors, animal pathophysiology, and vaccine development, it is 
possible that a vaccine will be developed that can more effectively prevent and decrease severity 
of liver abscesses in feedlot cattle.  
